Floatz logo

Monomethyl Fumarate

Myelodysplastic/Myeloproliferative Diseases

Memorial Sloan Kettering Cancer CenterSmall moleculePhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Myelodysplastic/Myeloproliferative Diseases cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Memorial Sloan Kettering Cancer Center
Phase 3BBB
Busulphan
Jacqueline Garcia, MD
Phase 2/3BBB
Romidepsin
Jacqueline Garcia, MD
Phase 2/3BBB
Fludarabine
Fred Hutchinson Cancer Center
Phase 3BBB
Anti-Thymoglobulin, Rabbit
M.D. Anderson Cancer Center
Phase 2/3BBB

View all 31 →

Same molecule, other indications

Monomethyl Fumarate is also rated in:

Blood Stem Cell Transplant FailureDormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi AnemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Refractory Anemia With Excess BlastsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →